A056090 Stock Overview
Innosys Co., Ltd. engages in the design and manufacture of orthopedic and body correction devices in South Korea and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
CG MedTech Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩1,204.00 |
| 52 Week High | ₩3,030.00 |
| 52 Week Low | ₩1,093.00 |
| Beta | -0.081 |
| 11 Month Change | -8.72% |
| 3 Month Change | -13.19% |
| 1 Year Change | n/a |
| 33 Year Change | 36.20% |
| 5 Year Change | 8.27% |
| Change since IPO | -75.28% |
Recent News & Updates
Shareholder Returns
| A056090 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | 3.8% | 2.3% | 0.9% |
| 1Y | n/a | 13.9% | -3.4% |
Return vs Industry: Insufficient data to determine how A056090 performed against the KR Medical Equipment industry.
Return vs Market: Insufficient data to determine how A056090 performed against the KR Market.
Price Volatility
| A056090 volatility | |
|---|---|
| A056090 Average Weekly Movement | 5.0% |
| Medical Equipment Industry Average Movement | 7.0% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in KR Market | 11.6% |
| 10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A056090 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: Insufficient data to determine A056090's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 111 | Ju mi Chung | www.inno-sys.net |
Innosys Co., Ltd. engages in the design and manufacture of orthopedic and body correction devices in South Korea and internationally. The company offers headless screws, cortex screws, and K-wires and pin; Aspiron and Maxima anterior cervical plate systems for use in anterior interbody screw/plate fixation of the cervical spine during the development of a cervical spinal fusion; ANAX OCT spinal system, a device for spinal surgery; Velofix PEEK SA cervical cages for cervical interbody fusion; and Velofix PEEK cage; and NeoIC PEEK cage, devices used with autograft or bone graft substitutes. It also provides Benefix interspinous fixation systems for the immobilization and stabilization of the spinous processes to support fusion; ANAX 5.5 posterior spinal fixation system; ANAX 5.5 MIS System, ANAX 5.5 CT Spinal System, U&I Retractor; Perfix spinal system, a posterior and non-cervical pedicle fixation system, that includes Iliac screw, MIS system, level extension device; Spinal Hook system that provides distraction, compression, axial rotation, and anterior-posterior correction of deformities from thoracic spine to sacral spine; and Neo IC Cylindrical, Velofix TLIF cage, and Neo IC Square cage.
CG MedTech Co.,Ltd. Fundamentals Summary
| A056090 fundamental statistics | |
|---|---|
| Market cap | ₩124.32b |
| Earnings (TTM) | ₩1.98b |
| Revenue (TTM) | ₩35.89b |
62.9x
P/E Ratio3.5x
P/S RatioIs A056090 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A056090 income statement (TTM) | |
|---|---|
| Revenue | ₩35.89b |
| Cost of Revenue | ₩18.67b |
| Gross Profit | ₩17.22b |
| Other Expenses | ₩15.24b |
| Earnings | ₩1.98b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 19.14 |
| Gross Margin | 47.97% |
| Net Profit Margin | 5.51% |
| Debt/Equity Ratio | 2.7% |
How did A056090 perform over the long term?
See historical performance and comparison